Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Capital Expenditures Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -17.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 34.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -6.72%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -5.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 15.89%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -47.73%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -11.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -43.42%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 27.22%
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -79.56%
Jun 30, 2025 -35.11%
Mar 31, 2025 54.08%
Dec 31, 2024 85.12%
Sep 30, 2024 843.50%
Jun 30, 2024 36.23%
Mar 31, 2024 69.52%
Dec 31, 2023 -18.06%
Sep 30, 2023 -56.36%
Jun 30, 2023 26.99%
Mar 31, 2023 -5.79%
Dec 31, 2022 -29.23%
Sep 30, 2022 24.63%
Jun 30, 2022 -39.29%
Mar 31, 2022 -10.70%
Dec 31, 2021 -1.88%
Sep 30, 2021 75.21%
Jun 30, 2021 29.40%
Mar 31, 2021 110.08%
Dec 31, 2020 34.03%
Sep 30, 2020 21.88%
Jun 30, 2020 460.81%
Mar 31, 2020 88.32%
Dec 31, 2019 50.63%
Sep 30, 2019 860.00%
Jun 30, 2019 -52.56%
Mar 31, 2019 3.79%
Dec 31, 2018 70.81%
Sep 30, 2018 -94.85%
Jun 30, 2018 -79.42%
Mar 31, 2018 -57.42%
Dec 31, 2017 -30.48%
Sep 30, 2017 -67.59%
Jun 30, 2017 -54.08%
Mar 31, 2017 -88.60%
Dec 31, 2016 -85.37%
Sep 30, 2016 220.17%
Jun 30, 2016 7,515.82%
Mar 31, 2016 5,475.35%
Dec 31, 2015 1,562.80%
Sep 30, 2015 395.86%
Jun 30, 2015 -64.04%
Mar 31, 2015 -11.22%
Dec 31, 2014 1,156.99%
Sep 30, 2014 74.04%
Jun 30, 2014 -46.30%
Mar 31, 2014 -88.50%
Dec 31, 2013 -101.70%
Sep 30, 2013 -87.48%
Jun 30, 2013 -78.54%
Mar 31, 2013 37.44%
Dec 31, 2012 47.44%
Sep 30, 2012 23.66%
Jun 30, 2012 362.69%
Mar 31, 2012 122.29%
Dec 31, 2011 -9.54%
Sep 30, 2011 -1.99%